Clinical Trial Update: Sorbent Therapy of the Cutaneous Porphyrias [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Sorbent Therapy addressing cutaneous porphyrias, including Phase 2 and Phase 3 studies in erythropoietic protoporphyria, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Sorbent Therapy

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Erythropoietic Protoporphyria | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-04-25